Ra Pharmaceuticals, Inc. — Form D
Ra Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-23. The offering totals $58.5M, of which $29.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-07-23
- Form: D
- Accession: 0001481512-15-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $58.5M
- Amount sold: $29.2M
- Remaining: $29.2M
- Investors: 11
- Date of first sale: 2015-07-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-244331
Issuer
- Name: Ra Pharmaceuticals, Inc.
- CIK: 0001481512
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: (617) 401-4060
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Peter A Bisgaard | Director | Redwood City, CA |
| Markus A Goebel | Director | Cambridge, MA |
| Jason A Lettman | Director | Cambridge, MA |
| Edward A Mathers | Director | Cambridge, MA |
| Rajeev A Shah | Director | Cambridge, MA |
| Douglas A Treco | Director | Cambridge, MA |
| Kerry A Black | Executive Officer | Cambridge, MA |
| Douglas A Treco | Executive Officer | Cambridge, MA |
| Theodore A Laufik | Executive Officer | San Diego, CA |
| Lauren W Silverman | Director | Boston, MA |
| Edward W Mathers | Director | Boston, MA |
| James W Broderick | Director | Malvern, PA |
Other filings by this issuer (1)
More